Hematological Malignancy
Links shared publicly online about this topic
New sources of drugs for hematologic malignancies
bloodjournal.hematologylibrary.org — “New sources of drugs for hematologic malignancies” View full resource at bloodjournal.hematologylibrary.org
Most Recently Shared on July 2, 2011 at 11:52 am By:
G Garcia-Manero Internist, Oncologist, Physician, and Doctor
how to retrofit old drugs for cancer therapy... http://fb.me/PfzgQpBn
Symposier - Pulmonary involvement in patients with hematological malignancies
symposier.com — “Uploaded and shared in Youtube by: VHIRtv — Dr. Elie Azoulay . Medical Intensive Care Department. Professeur Saint Louis Hospital, Paris Acute pulmonary events are among the most common complications in patients with hematological malignancies. These events often raise difficult diagnostic and therapeutic challenges. Clinicians faced with these challenges need a vast array of clinically relevant information contributed by physicians in many specialties who have acquired considerable experience o” View full resource at symposier.com
Most Recently Shared on March 15, 2012 at 5:08 pm By:
Pulmonary involvement in patients with hematological malignancies http://t.co/4yCmm2Ke
Infectious Dis. Medical News about hematologic malignancies
mdlinx.com — “How we treat influenza in patients with hematologic malignancies” View full resource at mdlinx.com
Most Recently Shared on December 23, 2009 at 1:16 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
I/D How we treat influenza in patients with hematologic malignancies: Blood http://bit.ly/6hJj4p
Oncology Conference: Hematologic Malignancies Demystified - New York
mdlinx.com — “View an extensive list of upcoming oncology conferences at MDLinx.com. These conferences are an effective way to stay informed about cancer or CME. Call us at 202-293-2288 for support.” View full resource at mdlinx.com
Most Recently Shared on January 22, 2011 at 10:02 pm By:
Great oncology conference today in NYC - Hematologic Malignancies Demystified - http://bit.ly/hqTXkv #hematology #cancer #oncology
Access Pharmaceuticals Furthers Clinical Development Program Of Thiarabine In Patients With Hematologic Malignancies
medicalnewstoday.com — “Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), announced it has initiated a Phase I/II dose-escalating study of its proprietary, anti-cancer drug, Thiarabine, a nucleoside analog for pa” View full resource at medicalnewstoday.com
Most Recently Shared on August 4, 2010 at 4:07 pm By:
Access Pharmaceuticals Furthers Clinical Development Program Of Thiarabine In Patients With Hematologic Malignancies http://mnt.to/3GXg
BioMarin Initiates Phase 1 Trial For BMN 673 In Patients With Advanced Hematological Malignancies
medicalnewstoday.com — “BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced the initiation of a Phase 1 trial for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, for the treatment of patients with advanced hema” View full resource at medicalnewstoday.com
Most Recently Shared on July 16, 2011 at 7:05 am By:
MNT Clinical Trials Health News
BioMarin Initiates Phase 1 Trial For BMN 673 In Patients With Advanced Hematological Malignancies http://mnt.to/3YjC #clinicaltrials
Cornerstone Pharmaceuticals Partners With Wake Forest University On Clinical Trial Of CPI-613 For Hematologic Malignancies
medicalnewstoday.com — “Cornerstone Pharmaceuticals, Inc., a private pharmaceutical company, with a singular focus on cancer metabolism, has announced that U.S. regulatory clearance has been obtained for the initiation o” View full resource at medicalnewstoday.com
Most Recently Shared on April 21, 2010 at 3:13 pm By:
Cornerstone Pharmaceuticals Partners With Wake Forest University On Clinical Trial Of CPI-613 For Hematologic Malignan... http://mnt.to/3Bxn
Hematologic Malignancies Demystified: Critical Appraisal of Data from ASH | prIME Oncology
primeoncology.org — “--Hematologic Malignancies Demystified: The Series-- A Critical Appraisal of Data from 2009 and ASH” View full resource at primeoncology.org
Most Recently Shared on February 19, 2011 at 1:18 am By:
Robert Z. Orlowski Physician, Doctor, and Internist
Will be speaking tomorrow at the Hematologic Malignancies Demystified meeting in Atlanta on new myeloma therapies (http://bit.ly/g1ta35).
New report providing insight for companies developing therapies to treat hematologic malignancies published
news-medical.net — “MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies developing therapies to treat hematologic malignancies.” View full resource at news-medical.net
Most Recently Shared on January 18, 2010 at 3:46 pm By:
Genetics News: New report providing insight for companies developing therapies to treat hematologic malignancies p... http://bit.ly/63pqzq
Advanced care planning helped patients with hematologic malignancies cope | HemOncToday
hemonctoday.com — “51st ASH Annual Meeting</P” View full resource at hemonctoday.com
Most Recently Shared on December 5, 2009 at 10:32 pm By:
HemOnc Today Oncology and Health News
#ASH09 Advanced care planning helped patients with hematologic malignancies cope http://ow.ly/J0EH
Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies
news-medical.net — “Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study of its novel heat shock protein 90 (Hsp90) inhibitor, STA-9090 in hematologic malignancies with a once-a-week dosing schedule.” View full resource at news-medical.net
Most Recently Shared on September 29, 2009 at 1:12 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic m.. http://bit.ly/2Ktm0B
Garlic and grape seed supplement use is inversely associated with hematological malignancies. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine
greenmedinfo.com — “This article on GreenMedInfo.com concerns - Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study.” View full resource at greenmedinfo.com
Most Recently Shared on August 2, 2011 at 1:58 pm By:
S*BIO's Oral Histone Deacetylase (HDAC) Inhibitor SB939 Shows Tolerability and Safety in Phase 1 Clinical Trial in Patients with Advanced Hematologic Malignancies - Drugs.com MedNews
drugs.com — “-Oral and Poster Presentations at 52nd ASH Annual Meeting and Exposition- SINGAPORE, S BIO Pte Ltd today announced that data from a Phase 1 study for its oral h” View full resource at drugs.com
Most Recently Shared on December 9, 2010 at 9:05 pm By:
Drugs and Devices OW OW Health
S*BIO's Oral Histone Deacetylase (HDAC) Inhibitor SB939 Shows Tolerability and Safety in Phase 1 Clinical ... http://bit.ly/hzXqS9 #drug
Infectious Dis. Medical News about Hematologic Neoplasms
mdlinx.com — “Antifungal prophylaxis and treatment in patients with hematological malignancies” View full resource at mdlinx.com
Most Recently Shared on May 14, 2010 at 5:22 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Antifungal prophylaxis and treatment in patients with hematological malignancies: Expert Review of Anti-infecti... http://bit.ly/d1xTPK #ID
Early, Aggressive Treatment Recommended For Critically Ill Patients With Hematological Malignancy
feeds.sciencedaily.com — “A study of 7,689 admissions from 178 adult intensive care units in England, Wales and Northern Ireland has revealed the factors associated with a higher mortality rate in hematological malignancy. Researchers found that certain factors have a significant impact on the risk of death.” View full resource at feeds.sciencedaily.com
Most Recently Shared on September 2, 2009 at 5:18 pm By:
Early, Aggressive Treatment Recommended For Critically Ill Patients With Hematological Malignancy: A study of 7,.. http://bit.ly/gKWsn
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
G Garcia-Manero
Leukemia physician and Professor of Medicine and Chief of Section of MDS at MD Anderson Cancer Center. Leukemia, Books, maybe some other staff.
-
Symposier Pneumology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
